ENGOT与妇科肿瘤学组（GOG）基金会对与行业合作伙伴开展试验的联合要求。 - Suppr | 超能文献

相似文献

1

Joint ENGOT and GOG Foundation requirements for trials with industry partners.ENGOT与妇科肿瘤学组（GOG）基金会对与行业合作伙伴开展试验的联合要求。

Gynecol Oncol. 2019 Aug;154(2):255-258. doi: 10.1016/j.ygyno.2019.04.677.

2

Joint ENGOT and GOG Foundation requirements for trials with industry partners.ENGOT与妇科肿瘤学组基金会（GOG Foundation）对与行业合作伙伴开展试验的联合要求。

Int J Gynecol Cancer. 2019 Sep;29(7):1094-1097. doi: 10.1136/ijgc-2019-000441. Epub 2019 Jul 18.

3

The GOG partners: A program for industry sponsored clinical trials in gynecologic oncology within the GOG foundation.GOG 合作伙伴：GOG 基金会内妇科肿瘤学领域产业赞助临床试验计划。

Gynecol Oncol. 2021 Jul;162(1):203-209. doi: 10.1016/j.ygyno.2021.03.010. Epub 2021 Mar 13.

4

European Network of Gynaecological Oncological Trial Groups' Requirements for Trials Between Academic Groups and Industry Partners--First Update 2015.欧洲妇科肿瘤试验组织网络对学术团体与行业合作伙伴间试验的要求——2015年首次更新

Int J Gynecol Cancer. 2015 Sep;25(7):1328-30. doi: 10.1097/IGC.0000000000000478.

5

Roadmap for the European Network of Gynaecological Trial groups (ENGOT) Trials.欧洲妇科临床试验网络（ENGOT）试验路线图。

Int J Gynecol Cancer. 2013 Sep;23(7):1339-43. doi: 10.1097/IGC.0b013e31829b87da.

6

European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groups and pharmaceutical companies.欧洲妇科肿瘤试验组织网络对学术团体与制药公司之间试验的要求。

Int J Gynecol Cancer. 2010 Apr;20(3):476-8. doi: 10.1111/IGC.0b013e3181d3caa8.

7

Report on NRG Oncology and the GOG Foundation.关于NRG肿瘤学与妇科肿瘤学组基金会的报告。

Gynecol Oncol. 2015 Oct;139(1):3-4. doi: 10.1016/j.ygyno.2015.08.021. Epub 2015 Aug 31.

8

Food and Drug Administration public hearing on the draft guidance for exception from informed consent requirements for emergency research: testimony of Novo Nordisk.美国食品药品监督管理局关于紧急研究知情同意要求豁免指南草案的公开听证会：诺和诺德公司的证词

Acad Emerg Med. 2007 Apr;14(4):e71-3. doi: 10.1197/j.aem.2006.12.001. Epub 2007 Feb 25.

9

A concern that drug companies cannot ignore.制药公司不能忽视的一个问题。

J R Soc Med. 2005 Oct;98(10):448-50. doi: 10.1177/014107680509801008.

10

Society of Gynecologic Oncology meeting highlights progress.妇科肿瘤学会会议强调了进展。

J Natl Cancer Inst. 2011 Apr 6;103(7):533-4. doi: 10.1093/jnci/djr121. Epub 2011 Mar 23.

引用本文的文献

1

The GOG Foundation and EVA/LACOG partnership: a collaborative strategic alliance for clinical trial execution.妇科肿瘤学组基金会与EVA/LACOG合作关系：临床试验执行的协作战略联盟。

Int J Gynecol Cancer. 2025 Jun 27:101991. doi: 10.1016/j.ijgc.2025.101991.

2

From the Beginning of the Korean Gynecologic Oncology Group to the Present and Next Steps.从韩国妇科肿瘤学组的创立至今及未来发展方向

Cancers (Basel). 2024 Oct 9;16(19):3422. doi: 10.3390/cancers16193422.

3

Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer.